No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ONTO240719P200000
- 2.80
- -1.04-27.08%
15min DelayClose Jul 1 16:00 ET
2.80High2.80Low
2.80Open3.84Pre Close1 Volume23 Open Interest200.00Strike Price280.00Turnover47.52%IV9.95%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry2.80Extrinsic Value100Contract SizeAmericanOptions Type-0.1745Delta0.0112Gamma96.26Leverage Ratio-0.1608Theta-0.0181Rho-16.79Eff Leverage0.1248Vega
Intraday
- 5D
- Daily
News
Onto Innovation (ONTO) Stock Moves -0.2%: What You Should Know
11 Favored Semiconductor Stocks Expected to Outperform Nvidia Over the Next Year
Onto Innovation (ONTO) Rose on Increased Demand
Onto Innovation Invites Customers and Investors to Schedule Meetings at SEMICON West
Onto Innovation (ONTO) Upgraded to Strong Buy: What Does It Mean for the Stock?
Semi Stocks Undergo Upgrades, Price Target Hikes on AI Demand: B Riley
Comments
Onto Innovation's declining ROCE trend is worrisome. Despite increased capital investment, returns and sales are dropping, possibly indicating a loss of competitive edge or market share. Despite poor fundamentals, investors remain hopeful due to significant stock growth in the past three years. However, if these trends persist, the company's long-term performance could suffer.
Returns On Capital Signal Tricky Times Ahead For Onto Innovation (NYSE:ONTO) 1
Onto Innovation Inc.'s high P/E ratio is worrying considering its lower predicted growth compared to the broader market. The current upbeat sentiment towards the company's stock may not last unless there's a substantial boost in its earnings growth.
Insiders selling shares of Onto Innovation Inc. slightly below current price could concern shareholders. Lack of recent insider transactions is neutral. 1.0% insider ownership suggests alignment with other shareholders. Yet, last 12 months' insider transactions are discouraging.
Observers warn falling returns may limit Onto Innovation's future growth even with apparent reinvestment. Despite strong stock performance, they suggest monitoring company earnings to see if investments pay off.
$Adtalem Global Education(ATGE.US$ $Beneficient(BENF.US$ $Ebix Inc(EBIX.US$ $Emergent BioSolutions(EBS.US$ $EnerSys(ENS.US$ $ESGL Holdings(ESGL.US$ $FutureFuel(FF.US$ $IonQ Inc(IONQ.US$ $Maxeon Solar Technologies(MAXN.US$ $MercadoLibre(MELI.US$ $Macrogenics(MGNX.US$ $Novo-Nordisk A/S(NVO.US$ $Onto Innovation(ONTO.US$ $Oracle(ORCL.US$ $Pagaya Technologies(PGY.US$ $Xtant Medical(XTNT.US$
1
Read more